Is AKBLF or JNJ a better dividend investment in 2026?

AKBLF currently yields 0.80% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: JNJ offers higher current income.

What is the dividend yield difference between AKBLF and JNJ?

AKBLF has a forward dividend yield of 0.80% ($0.25/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2.56 percentage points.

Home › Compare › AKBLF vs JNJ

AKBLF vs JNJ: Dividend Comparison 2026

AKBLF yields 0.80% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AKBLF wins by $779.00 in total portfolio value

INVESTMENT

TIME HORIZON10 years

AKBLF

● Live price

0.80%

Share price

$31.35

Annual div

$0.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.8K

Annual income

$83.98

Full AKBLF calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — AKBLF vs JNJ

📍 AKBLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AKBLF	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AKBLF + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AKBLF pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKBLF

Annual income on $10K today (after 15% tax)

$67.78/yr

After 10yr DRIP, annual income (after tax)

$71.38/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, JNJ beats the other by $632.23/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKBLF + JNJ for your $10,000?

AKBLF: 50%JNJ: 50%

100% JNJ50/50100% AKBLF

Portfolio after 10yr

$20.4K

Annual income

$455.88/yr

Blended yield

2.23%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AKBLF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

11.6

Piotroski

8/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKBLF buys

JNJ buys

No recent congressional trades found for AKBLF or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAKBLFJNJ

Forward yield	0.80%	3.36% ✓
Annual dividend / share	$0.25	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$20.8K ✓	$20.0K
Annual income after 10y	$83.98	$827.78 ✓
Total dividends collected	$820.00 ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: AKBLF vs JNJ ($10,000, DRIP)

Year	AKBLF Portfolio	AKBLF Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$10,780	$79.74	$10,676	$355.77	+$104.00 → AKBLF
2	$11,615	$80.34	$11,407	$389.39	+$208.00 → AKBLF
3	$12,509	$80.90	$12,198	$426.53	+$311.00 → AKBLF
4	$13,466	$81.43	$13,056	$467.62	+$410.00 → AKBLF
5	$14,490	$81.92	$13,987	$513.12	+$503.00 → AKBLF
6	$15,587	$82.39	$14,998	$563.56	+$589.00 → AKBLF
7	$16,761	$82.82	$16,098	$619.52	+$663.00 → AKBLF
8	$18,017	$83.24	$17,295	$681.69	+$722.00 → AKBLF
9	$19,362	$83.62	$18,599	$750.82	+$763.00 → AKBLF
10	$20,801	$83.98	$20,022	$827.78	+$779.00 → AKBLF

AKBLF vs JNJ: Complete Analysis 2026

AKBLF — Stock

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Full AKBLF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this AKBLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKBLF vs SCHD AKBLF vs JEPI AKBLF vs O AKBLF vs KO AKBLF vs MAIN AKBLF vs ABBV AKBLF vs MRK AKBLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.